Axsome (AXSM) Stock Up 17% in Six Months: Here's Why - Yahoo …

Mar 20, 2023 · Axsome's (AXSM) shares have surged 17.2% in the past six months, owing to the launch of its first product, Auvelity, in October last year. Also, the addition of Sunosi boosts its …

17%
OFF

Axsome (AXSM) Stock Up 17% In Six Months: Here's Why - Yahoo …

2 weeks from now

Mar 20, 2023 · Axsome's (AXSM) shares have surged 17.2% in the past six months, owing to the launch of its first product, Auvelity, in October last year. Also, the addition of Sunosi boosts its …

yahoo.com

17%
OFF

Axsome (AXSM) Stock Up 17% In Six Months: Here's Why

2 weeks from now

Mar 20, 2023 · Shares of Axsome AXSM have surged 17.2% in the past six months against the industry's 0.4% decline. ... Axsome (AXSM) Stock Up 17% in Six Months: Here's Why March …

nasdaq.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

20 hours ago · Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of …

yahoo.com

4%
OFF

Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?

2 weeks from now

Mar 21, 2024 · A month has gone by since the last earnings report for Axsome Therapeutics (AXSM). Shares have lost about 4% in that time frame, underperforming the S&P 500. ... up …

nasdaq.com

1%
OFF

Why Is Axsome (AXSM) Down 0.1% Since Last Earnings Report?

2 weeks from now

Dec 12, 2024 · It has been about a month since the last earnings report for Axsome Therapeutics (AXSM). Shares have lost about 0.1% in that time frame, underperforming the S&P 500.

yahoo.com

2%
OFF

Axsome Therapeutics Stock Dives On Mixed Results In Alzheimer's ...

2 weeks from now

Dec 30, 2024 · Axsome stock skidded 2.2% to close at 84.78. Shares were already below their 50-day line, but made a definitive drop below their 200-day moving average at the open. …

investors.com

$180
OFF

Truist Raises Axsome Stock Target To $180, Maintains Buy Rating

2 weeks from now

5 days ago · On Friday, Truist Securities updated its outlook on Axsome Therapeutics (NASDAQ: AXSM), increasing the price target on the company's stock to $180 from the previous target of …

investing.com

$89.27
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected To …

2 weeks from now

1 day ago · Axsome Therapeutics stock opened at $89.27 on Monday. Axsome Therapeutics has a 12 month low of $64.11 and a 12 month high of $105.00. The business’s fifty day simple …

etfdailynews.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last? - MSN

2 weeks from now

Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of shares changing …

msn.com

1%
OFF

Why Is Axsome (AXSM) Down 0.1% Since Last Earnings Report?

2 weeks from now

Dec 12, 2024 · Notably, Axsome has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Performance of an Industry Player. Axsome is part of the …

tradingview.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

1 day ago · Axsome Therapeutics (AXSM Quick Quote AXSM - Free Report) shares ended the last trading session 11.5% higher at $89.27.The jump came on an impressive volume with a …

zacks.com

$92.17
OFF

Axsome Therapeutics' (AXSM) "Buy" Rating Reaffirmed At …

2 weeks from now

1 day ago · The company's stock had a trading volume of 126,969 shares, compared to its average volume of 765,308. The company's 50 day simple moving average is $92.17 and its …

marketbeat.com

$86.70
OFF

Axsome Therapeutics (NASDAQ:AXSM) Shares Gap Down – Here’s …

2 weeks from now

Dec 30, 2024 · Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price gapped down prior to trading on Monday .The stock had previously closed at $86.70, but …

etfdailynews.com

$129.43
OFF

Truist Financial Forecasts Strong Price Appreciation For Axsome ...

2 weeks from now

2 days ago · According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $129.43. Get Our Latest Stock Report on …

marketbeat.com

5%
OFF

Here's Why Axsome Therapeutics Is On The Move Today

2 weeks from now

Dec 3, 2019 · As of 11:52 a.m. EST the stock was up 12.5%. So what Axsome popped after reading out results from Concert, a phase 2 study involving AXS-12 and narcolepsy patients …

fool.com

3%
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 5.3% On

2 weeks from now

2 days ago · Axsome Therapeutics Stock Up 7.8 %. The stock has a market capitalization of $4.18 billion, a P/E ratio of -13.21 and a beta of 1.04. The company has a current ratio of 2.44, …

marketbeat.com

$9.22
OFF

Pallas Capital Advisors LLC Purchases Shares Of 26,435 Axsome ...

2 weeks from now

2 days ago · Axsome Therapeutics Trading Up 11.5 %. Shares of NASDAQ:AXSM traded up $9.22 on Monday, hitting $89.27. 1,879,117 shares of the company's stock were exchanged, …

marketbeat.com

FAQs about Axsome (AXSM) Stock Up 17% in Six Months: Here's Why - Yahoo … Coupon?

Why has Axsome axsm stock soared in the past 6 months?

Shares of Axsome AXSM have surged 17.2% in the past six months against the industry's 0.4% decline. The upside can be attributed to FDA’s approval for Auvelity (“AXS-05”), for treating major depressive disorder, the addition of Sunosi to its marketed portfolio and rapid progress of its pipeline of central nervous system (CNS) disorder candidates. ...

Will Axsome Therapeutics (axsm) move 11.5% higher?

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last? Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. ...

Should you buy axsm (axsm) stock?

Losses were -$239.24 million, 27.8% more than in 2022. According to 14 analysts, the average rating for AXSM stock is "Strong Buy." The 12-month stock price forecast is $125.93, which is an increase of 39.77% from the latest price. ...

How much did Axsome Therapeutics (axsm) raise?

Axsome Therapeutics (AXSM) raised $52 million in an initial public offering on Thursday, November 19th 2015. The company issued 4,300,000 shares at a price of $11.00-$13.00 per share. Ladenburg Thalmann and Cantor Fitzgerald & Co. served as the underwriters for the IPO and Brean Capital was co-manager. ...

Should you buy Axsome (AXS) stock?

According to 14 analysts, the average rating for AXSM stock is "Strong Buy." The 12-month stock price forecast is $125.93, which is an increase of 39.77% from the latest price. Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. ...

Should you buy Axsome Therapeutics (axsm) in 2023?

In 2023, Axsome Therapeutics's revenue was $270.60 million, an increase of 440.80% compared to the previous year's $50.04 million. Losses were -$239.24 million, 27.8% more than in 2022. According to 14 analysts, the average rating for AXSM stock is "Strong Buy." ...